Sacituzumab Tirumotecan Approval in China By
December 16, 2024 05:19 ET
|
KuicK Research
Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The recent approval of sacituzumab tirumotecan in China represents a significant advancement in oncology, particularly in the realm of targeted therapies....
TROP2 Targeted Cancer Therapy Market Clinical Trials Companies Insight
March 20, 2023 02:55 ET
|
KuicK Research
Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- Global TROP2 Antibody Market, Drug Sales & Clinical Trials Outlook 2028 Report Highlights: Global & Regional TROP2 Antibody Market Sales...
TROP2 Antibodies Drug Conjugate ADC Clinical Trials Market Opportunity 2028
February 22, 2023 07:33 ET
|
KuicK Research
Delhi, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Global TROP2 Antibody Market, Drug Sales & Clinical Trials Outlook 2028 Report Highlights: Global & Regional TROP2 Antibody Market Sales...
FDA Approved TROP2 Antibody Market Opportunity Market Forecast Report 2026
November 16, 2021 06:25 ET
|
KuicK Research
Delhi, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Delhi, India: Global TROP2 Antibody Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: Research MethodologyGlobal & Regional...